Lito Sousa: Medicinal Product Arriving in Brazil - 13/09/2026 - Equilibrio E Saúde

Globo

Lean Right

Factuality

Ownership

Lito Sousa in video published on Friday (4) Reproduction A joint operation between the Federal Revenue and the National Agency for Health Surveillance (Anvisa) allowed the rapid release of the experimental drug intended for the treatment of the influencer Lito Sousa, diagnosed with Creutzfeldt-Jakob disease. Agility was necessary because the therapeutic potential of the substance decreases rapidly over the hours. On September 4, Anvisa authorize…

UOL

Folha de S.Paulo

View article

Reposted by

Folha de S.Paulo

Lean Left

Factuality

Ownership

Federal Revenue and Anvisa anticipated procedures to release the medication a few minutes after their arrival in Brazil

Portal GMC Online

Factuality

Ownership

The experimental medicine for the treatment of the influencer Lito Sousa arrived in Brazil in the morning of Saturday, 12, and had the customs clearance

Jovem Pan News

Factuality

Ownership

Request was sent to the U.S. by Mila Seidl, Lito's wife, in partnership with the doctor of the case, who asked Anvisa for authorization for the individual use of the medicine

Correio do Povo

Factuality

Ownership

Federal Revenue and Anvisa expedite procedures for entry of the substance

Portal Mix Vale

Factuality

Ownership

The Federal Revenue released in a few minutes at São Paulo International Airport in Guarulhos, on September 11, 2026, an emergency medicine taken by helicopter to pilot Lito Sousa, 59, served at Einstein Israeli Hospital. The cargo arrived in the country at the end of the night of September 11, 2026 to [...]